25 Stocks Moving in Friday's Pre-Market Session

Gainers

  • iSpecimen Inc. ISPC rose 56.9% to $16.00 in pre-market trading. The company recently announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
  • Allied Healthcare Products, Inc. AHPI rose 29.6% to $6.98 in pre-market trading. Covid-related stocks surged on reports of new, heavily-mutated strain, feared to be more infectious than Delta variant.
  • Valneva SE VALN rose 18.1% to $58.93 in pre-market trading. Valneva recently signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply up to 60 million doses of its inactivated COVID-19 vaccine candidate VLA2001, over two years.
  • BIMI International Medical Inc. BIMI rose 16.9% to $0.8210 in pre-market trading. BIMI recently priced its private placement for $7.8 million in proceeds.
  • Alpha Pro Tech, Ltd APT shares rose 15.2% to $5.90 in pre-market trading. Covid-related stocks surged on reports of new, heavily-mutated strain, feared to be more infectious than Delta variant.
  • Aptevo Therapeutics Inc. APVO rose 11.4% to $13.31 in pre-market trading. Aptevo Therapeutics recently announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 in the treatment of AML. Preliminary data observed to date includes one complete remission.
  • Ocugen, Inc. OCGN rose 10.9% to $7.87 in pre-market trading. Covid-related stocks surged on reports of new, heavily-mutated strain, feared to be more infectious than Delta variant.
  • Nautilus, Inc. NLS rose 9.9% to $7.81 in pre-market trading.
  • Co-Diagnostics, Inc CODX rose 9.7% to $9.30 in pre-market trading.
  • iBio, Inc. IBIO rose 9.7% to $0.73 in pre-market trading.
  • GeoVax Labs, Inc. GOVX rose 9.5% to $4.25 in pre-market trading. GeoVax recently highlighted presentation of COVID-19 vaccine data at Vaccine World Asia Congress.
  • Zoom Video Communications, Inc. ZM shares rose 9.4% to $227.88 in pre-market trading amid concerns of a new COVID variant found in South Africa, which has lifted remote work and virtual communication stocks.
  • BeyondSpring Inc. BYSI rose 9.1% to $14.49 in pre-market trading after gaining 5% on Wednesday.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Selecta Biosciences, Inc. SELB fell 15.1% to $2.70 in pre-market trading after the company disclosed that the FDA has issued clinical hold on its Phase 1/2 clinical trial of SEL-302 due to CMC related questions.
  • Oncolytics Biotech Inc. ONCY fell 14.9% to $1.60 in pre-market trading. Oncolytics Biotech will present Phase 2 triple-negative breast cancer trial update at 2021 San Antonio Breast Cancer Symposium Dec. 9.
  • RAVE Restaurant Group, Inc. RAVE shares fell 14.4% to $1.31 in pre-market trading after gaining 5% on Wednesday.
  • Callon Petroleum Company CPE fell 12.2% to $54.18 in pre-market trading after jumping around 6% on Wednesday.
  • BIOLASE, Inc. BIOL fell 12.1% to $0.4130 in pre-market trading. Biolase shares gained 12% on Wednesday after the company announced Nasdaq granted its request for a 180-day extension to regain compliance with Nasdaq's minimum bid price requirement.
  • Mechel PAO MTL shares fell 11.1% to $2.87 in pre-market trading. Mechel recently reported Q3 sales of 102.9 billion Rubles.
  • Carnival Corporation & plc CUK fell 11% to $16.54 in pre-market trading after a new COVID variant was discovered in South Africa, which has clouded travel outlook.
  • Canoo Inc. GOEV shares fell 11% to $11.02 in pre-market trading after surging 7% on Wednesday.
  • Reliance Global Group, Inc. RELI shares fell 10% to $2.33 in pre-market trading following a 7% gain on Wednesday.
  • Royal Caribbean Cruises Ltd. RCL fell 9.8% to $70.55 in pre-market trading after a new COVID variant was discovered in South Africa, which has clouded travel outlook.
  • Gracell Biotechnologies Inc. GRCL fell 8.2% to $6.51 in pre-market trading. Gracell Biotechnologies recently reported members of its senior management team intend to use personal funds to buy up to $2 million in company ADSs in the open market over the next 3 months.
  • NOV Inc. NOV shares fell 7.4% to $11.91 in pre-market trading. NOV, last week, said it reinstated regular quarterly dividend of $0.05 per share.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!